Robert joined Galapagos in January 2024 as Global Head of Technical Operations. He will lead Galapagos’ global cell therapy operations, including manufacturing, Quality Control (QC), Chemistry, Manufacturing and Controls (CMC), process development, analytical development, and technology transfer.
Robert brings a wealth of experience and has a rich background in the biopharmaceutical industry. He previously served as SVP & Global Head of Bioindustry at Miltenyi Biotec and VP & GM at Siegfried Holding AG and held operational leadership positions in several multinational organizations. In his most recent role at Miltenyi, he gained a deep understanding of cell therapy manufacturing and CMC.
Robert holds a Master of Business Administration from Kaplan University and a Bachelor of Science from the San Diego State University.